Pylera Capsule
Product Images NDC 61269-380

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pylera (NDC 61269-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pylera 01)

Chemical structure of metronidazole, showing its nitroimidazole ring with attached hydroxymethyl and methyl groups. The image depicts the molecular arrangement of atoms in metronidazole, one of the active ingredients in PYLERA capsules.*

FDA Label Image

Chemical Structure (Pylera 02)

Chemical structure diagram of tetracycline hydrochloride, showing its molecular arrangement with hydroxyl, amine, methyl groups, and hydrochloride component.*

FDA Label Image

Principal Display Panel (120 Capsule Blister Card Box)

PYLERA capsules packaging label for oral capsules containing bismuth subcitrate potassium 140 mg, metronidazole 125 mg, and tetracycline HCl 125 mg. The label indicates a 10 Day Therapy PAK with 120 capsules in 10 blister cards, each card containing 4 blisters with 3 capsules per blister. Manufactured by H2-Pharma, LLC, the label includes usage indication for Helicobacter pylori eradication and features the JUVISÉ Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.